英文摘要 |
The survival rate of liver transplant patients significantly improved in recent years with the refinement of surgical techniques and perioperative care. Liver transplantation became the best treatment strategy for various end-stage liver diseases. Extracorporeal support system raises the utilization rate of liver grafts from severe steatosis as well as grafts from resuscitation from cardiac arrest, successfully ameliorating the shortage of liver graft supply. Early transplantation and the use of individualized evaluation increases the survival rate of patients with alcoholic liver disease, and further lowers the impact of hepatic steatosis-associated comorbidities on the survival rates following transplantation. Systemic anti-cancer therapy for patients with hepatocellular carcinoma (HCC) before and after liver transplantation not only provides patients who were initially eligible for surgery an opportunity to receive transplantation but also prolongs the survival of patients with HCC recurrence. Minimally invasive surgery has been widely applied in donor hepatectomy, which both reduces perioperative pain/stress and decreases the length of hospitalized days. Finally, the emerging techniques of 3D printing and artificial intelligence provide a more precise therapy for liver transplantation surgery and further optimize the outcome of liver transplantation. |